NEUROFIBROMATOSIS AND ORAL-CONTRACEPTIVE THERAPY

被引：0
|
作者：
PROUDFIT, CM
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1980年 / 243卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2526 / 2526
页数：1
相关论文
共 50 条
  • [41] THE INFLUENCE OF ORAL-CONTRACEPTIVE THERAPY ON THE PERIODONTIUM - DURATION OF DRUG-THERAPY
    PANKHURST, CL
    WAITE, IM
    HICKS, KA
    ALLEN, Y
    HARKNESS, RD
    JOURNAL OF PERIODONTOLOGY, 1981, 52 (10) : 617 - 620
  • [42] BREAST-CANCER AND ORAL-CONTRACEPTIVE THERAPY IN PREMENOPAUSAL WOMEN
    GAMBRELL, RD
    MASSEY, FM
    CASTANEDA, TA
    BODDIE, AW
    JOURNAL OF REPRODUCTIVE MEDICINE, 1979, 23 (06) : 265 - 271
  • [43] GALACTORRHEA IN ORAL-CONTRACEPTIVE USERS
    HOLTZ, G
    JOURNAL OF REPRODUCTIVE MEDICINE, 1982, 27 (04) : 210 - 212
  • [44] CYTOLOGICAL EFFECTS OF ORAL-CONTRACEPTIVE
    BISHUN, N
    SMITH, N
    WILLIAMS, D
    MILLS, J
    MUTATION RESEARCH, 1976, 39 (01): : 97 - 110
  • [45] THE TETRACYCLINE - ORAL-CONTRACEPTIVE CONTROVERSY
    HUDSON, CP
    CALLEN, JP
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 7 (02) : 269 - 270
  • [46] INTERCHANGEABILITY OF ORAL-CONTRACEPTIVE PRODUCTS
    RUEDY, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1992, 146 (02) : 108 - 108
  • [47] CHINESE MONTHLY ORAL-CONTRACEPTIVE
    FAUVEAU, V
    PHIMMASONE, K
    LANCET, 1994, 343 (8891): : 239 - 239
  • [48] MORTALITY IN ORAL-CONTRACEPTIVE USERS
    VESSEY, MP
    MCPHERSON, K
    YEATES, D
    LANCET, 1981, 1 (8219): : 549 - 550
  • [49] THROMBOEMBOLISM AND THE COMBINED ORAL-CONTRACEPTIVE
    GIRARD, M
    LANCET, 1995, 346 (8970): : 317 - 317
  • [50] ORAL-CONTRACEPTIVE INDUCED PARABALLISM
    DRIESEN, JJM
    WOLTERS, EC
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1987, 89 (01) : 49 - 51
12345